Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 465Session 2026

classifying xylazine as a schedule III controlled drug.

Read the full bill

Progress

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed legislature Not yet
  5. Sent to governor Not yet
  6. Became law Not yet

Legislative history

  1. House

    Inexpedient to Legislate: MA VV 04/23/2026 HJ 11 P. 55

  2. House

    Minority Committee Report: Ought to Pass

  3. House

    Majority Committee Report: Inexpedient to Legislate 04/14/2026 (Vote 11-5; RC)

  4. House

    Executive Session: 04/14/2026 01:00 pm GP 153

  5. House

    Full Committee Work Session: 04/07/2026 01:00 pm GP 153

  6. House

    Public Hearing: 03/31/2026 01:30 pm GP 153

  7. House

    Introduced (in recess of) 03/12/2026 and referred to Environment and Agriculture HJ 8 P. 114

  8. Senate

    Ought to Pass with Amendment #2026-0842s, MA, VV; OT3rdg; 03/05/2026; SJ 5

  9. Senate

    Committee Amendment # 2026-0842s, AA, VV; 03/05/2026; SJ 5

  10. Senate

    Committee Report: Ought to Pass with Amendment # 2026-0842s, 03/05/2026; Vote 5-0; CC; SC 8

  11. Senate

    Hearing: 02/10/2026, Room 100, SH, 01:30 pm; SC 5A

  12. Senate

    Introduced 01/07/2026 and Referred to Judiciary; SJ 1